Physician profile
Janet Li
NPI 1609212158
$9,392.49
in general payments reported to CMS, 2019-2025
33 companies · $1,550 in 2025
The $1,550 reported for 2025 was more than what 84% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,255 · 2020: $1,173 · 2021: $1,168 · 2022: $1,273 · 2023: $1,593 · 2024: $1,380 · 2025: $1,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,522.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,039.98 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,252.23 | 2019-2025 | Dupixent |
| Organogenesis INC. | $713.74 | 2021-2024 | Puraply |
| Sun Pharmaceutical Industries INC. | $596.54 | 2019-2025 | Odomzo, Blu-U |
| Genzyme Corporation | $584.66 | 2021-2025 | |
| Janssen Biotech, INC. | $501.79 | 2020-2025 | Tremfya |
| Amgen INC. | $474.26 | 2019-2025 | Otezla, Otezla |
| Incyte Corporation | $370.04 | 2022-2025 | Opzelura |
| Leo Pharma INC. | $335.00 | 2019-2024 | Adbry |
| Ucb, INC. | $323.95 | 2020-2025 | Bimzelx |
| Lilly USA, LLC | $304.48 | 2020-2025 | Taltz, Ebglyss |
| Galderma Laboratories, L.P. | $275.15 | 2019-2025 | Nemluvio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $244.95 | 2020-2025 | Jublia, Arazlo, Cabtreo |
| Paratek Pharmaceuticals, INC. | $170.43 | 2021-2023 | Nuzyra |
| Pfizer INC. | $164.92 | 2019-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $148.04 | 2020-2025 | |
| Arcutis Biotherapeutics, INC. | $136.30 | 2024-2025 | Zoryve |
| Celgene Corporation | $109.01 | 2019 | |
| Almirall LLC | $108.86 | 2020-2025 | Klisyri, Seysara |
| Organon LLC | $76.79 | 2025 | Vtama |
| Journey Medical Corporation | $71.14 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $68.61 | 2024-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $49.64 | 2025 | |
| Dermavant Sciences, INC. | $48.79 | 2024 | Vtama |
| Genentech USA, INC. | $45.83 | 2021-2022 | |
| Hill Dermaceuticals, INC. | $44.91 | 2021 | |
| Kerecis Limited | $24.18 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Vyne Pharmaceuticals INC. | $23.83 | 2020 | |
| Next Science LLC | $22.19 | 2024 | Surgx, Blastx, Xperience |
| Verrica Pharmaceuticals INC. | $17.61 | 2025 | Ycanth |
| Phadia US INC. | $15.54 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.45 | 2023 | Evusheld |
| Dermira, INC. | $13.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.